Moleculin Biotech furnishes November 2025 corporate presentation; content not disclosed in filing text

Moleculin Biotech, Inc.

Filing under Item 7.01: corporate presentation posted on company website as Exhibit 99.1.
Presentation date: November 2025. No specific financial or operational data included in the filing.
Company ticker: MBRX (NASDAQ). No changes in guidance, earnings, or leadership disclosed.
Given absence of presentation content, material impact cannot be assessed from this filing alone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.